Valuation: H&R GmbH & Co. KGaA

Market Cap 246M 276M 228M 207M 387M 26.26B 392M 2.74B 1.08B 13.76B 1.04B 1.02B 43.33B P/E 2026 *
4.66x
P/E 2027 * 14.1x
Enterprise Value 269M 302M 249M 226M 423M 28.7B 429M 2.99B 1.18B 15.03B 1.13B 1.11B 47.35B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.19x
Free-Float
21.97%
Yield 2026 *
2.27%
Yield 2027 * 1.51%
Aug. 14 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
May. 15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Mar. 31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Jan. 28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
Nov. 14 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
Nov. 14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25-08-24 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
25-08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-15 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
25-05-13 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-16 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
25-04-08 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-26 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
1 day-2.65%
1 week-2.65%
Current month-10.54%
1 month-11.26%
3 months+3.44%
6 months+43.91%
Current year+54.31%
1 week 6.38
Extreme 6.38
7.04
1 month 6.38
Extreme 6.38
7.6
Current year 3.91
Extreme 3.91
7.6
1 year 3.91
Extreme 3.91
7.6
3 years 3.23
Extreme 3.23
7.6
5 years 3.23
Extreme 3.23
9.22
10 years 3.23
Extreme 3.23
16.76
Manager TitleAgeSince
Chief Executive Officer 61 2015-12-31
Investor Relations Contact - 2005-12-31
Director TitleAgeSince
Chairman 62 2012-04-16
Director/Board Member 71 2011-04-30
Director/Board Member 69 2011-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-2.65%-2.65%+34.55%+35.93% 276M
-0.30%+2.09%+14.09%+38.55% 235B
+0.63%+0.88%+11.39%+37.41% 125B
-2.48%+0.55%+0.92%+43.44% 81.34B
-6.08%-1.95%+593.55%+375.51% 73.24B
-0.35%+2.52%+20.49%+10.79% 68.4B
-1.65%-3.50%-28.75%-43.42% 34.95B
+1.58%+1.00%+8.87%-20.98% 31.4B
-2.19%+3.00%+6.87%-9.96% 24.59B
+2.51%+8.95%+31.44%-33.77% 23.69B
Average -1.10%+1.51%+69.34%+43.35% 69.69B
Weighted average by Cap. -0.96%+1.57%+71.55%+60.64%

Financials

2026 *2027 *
Net sales 1.4B 1.57B 1.3B 1.18B 2.2B 149B 2.23B 15.6B 6.17B 78.31B 5.9B 5.78B 247B 1.37B 1.53B 1.27B 1.15B 2.15B 146B 2.18B 15.23B 6.02B 76.45B 5.76B 5.64B 241B
Net income 52.99M 59.39M 49M 44.41M 83.24M 5.65B 84.4M 589M 233M 2.96B 223M 218M 9.32B 17.34M 19.43M 16.03M 14.53M 27.24M 1.85B 27.62M 193M 76.26M 968M 72.97M 71.42M 3.05B
Net Debt 22.87M 25.63M 21.14M 19.16M 35.92M 2.44B 36.42M 254M 101M 1.28B 96.24M 94.2M 4.02B 8.65M 9.7M 8M 7.25M 13.59M 922M 13.78M 96.22M 38.05M 483M 36.41M 35.64M 1.52B
Projected Income Statement - Annual - H&R GmbH & Co. KGaA
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
26-10-23 €6.620 -2.65% 37,856
26-10-22 €6.800 +0.29% 2,547
26-10-21 €6.780 0.00% 1,740
26-10-20 €6.780 -1.45% 3,591
26-10-19 €6.880 +1.18% 2,644
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - H&R GmbH & Co. KGaA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.620EUR
Average target price
7.700EUR
Spread / Average Target
+16.31%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - H&R GmbH & Co. KGaA
  1. Stock Market
  2. Stocks
  3. 2HRA Stock